BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
FABP1
,
glucose metabolic process
,
Obesity
,
Endothelial cell
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD38 protein
Summary
General Info
Curated Studies
Most Correlated Studies
Cultured hematopoietic stem and progenitor cells treated with CCL28 and SCF
Tonsil centroblast cells CD19+ CD38hi CD10+ IgD- CXCR4+ stimulated with CD40L and IL21
Hematopoietic stem cells co-cultured with mesenchymal stromal cells and treated wtih Stanniocalcin 1
Acute myeloid leukemia blasts and T cells treated with granulocyte-colony stimulating factor
Whole blood of scleroderma patients treated with MEDI-551 (anti-CD19) and samples of healthy donors
Explore Curated Studies Results
Literature
Most Relevant Literature
The potential of CD38 protein as a target for autoimmune diseases.
Cell-Intrinsic CD38 Expression Sustains Exhausted CD8+ T Cells by Regulating Their Survival and Meta…
Comprehensive Proteomics Analysis Identifies CD38-Mediated NAD+ Decline Orchestrating Renal Fibrosis…
Implications of the NADase CD38 in COVID pathophysiology.
The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Ba…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selec…
Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple…
Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myel…
Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation o…
Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ